Skip to main content

GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms/0.5mL, suspension for injection, syringe (Merck Sharp & Dohme (Australia) Pty Ltd)

Product name
GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms/0.5mL, suspension for injection, syringe
Product type
Prescription Medicines
Testing category
Batch release evaluation
Reason for testing
Batch Release
Publication result
PASS
Publication release
May-2021
Batch number
T023022
Expiry date
Sample number
2008002946

Help us improve the Therapeutic Goods Administration site